The first-of-its-kind collaboration between the organizations is aimed at increasing industry-academia knowledge sharing in emerging technology areas like Precision care, Robotics, Cybersecurity, Artificial Intelligence, and 5G to improve the innovation ecosystem and accelerate local manufacturing.
Bengaluru, INDIA - January 23, 2024: Wipro GE Healthcare, a leading global medical technology, diagnostics, and digital solutions innovator today signed a Memorandum of Understanding (MoU) with the Indian Institute of Science (IISc), India’s premier research institution, for a pioneering alliance to advance healthcare innovation, research, and technology development in India. This collaboration aims to take a comprehensive approach in solving the care gap by addressing the full lifecycle that includes co-developing solutions, validating the technologies, and manufacturing them locally to bring them to the market. With the impending commencement of the Bagchi-Parthasarathy Hospital & IISc Medical School, this strategic collaboration will enable translation of technologies from bench to bedside.
According to World Health Organization Report 2018, “Globally, Non-Communicable Diseases (NCDs) accounted for 71% of total deaths. In India, NCDs were estimated to account for 63% of all deaths, and cancer was one of the leading causes (9%).”[1] This industry-academia collaboration aims to advance indigenous innovation and manufacturing of MedTech products that meets the needs of both global and local patients suffering from NCDs including cancer, cardiology, and neurology in line with the agenda of ‘Atmanirbhar Bharat’.
The collaboration will entail co-development initiatives in the areas of basic and applied science, systems engineering, product & software development, consultancy, publications, academic studies, internships, fellowships, and training. IISc and GE HealthCare will constitute a joint working committee, comprising representatives from both sides, for research around product and solution development.
Inframe From Left to Right: P S Anil Kumar, Dean of Administration & Finance, Indian Institute of Science (IISc), Govindan Rangarajan, Director, Indian Institute of Science (IISc), Chaitanya Sarawate, Managing Director, Wipro GE Healthcare and President & CEO, GE HealthCare South Asia, Girish Raghavan, VP – Engineering, GE HealthCare
Govindan Rangarajan, Director, Indian Institute of Science (IISc), said, “We see a tremendous need for innovative R&D that can improve outcomes in patients with NCD. The collaboration will emphasize combining science and engineering with translational & clinical research to epitomize “bench-to-bedside” innovation. GE HealthCare is the right partner for us in this initiative, given their leadership and strong footprint in India for R&D and manufacturing. We are confident that together, we can accelerate India’s position as a global force for healthcare for the world.”
Chaitanya Sarawate, Managing Director, Wipro GE Healthcare and President & CEO, GE HealthCare South Asia, said, “India today is at an inflection point, with a potential to become the hub for the world. IISc is a premier educational institute engaged in technical education, basic and applied research, innovation, entrepreneurship, and industrial consultancy and GE HealthCare is a world leader in MedTech with strategic R&D and manufacturing footprint in India. This is a strategic collaboration that combines the strengths, capabilities, and local infrastructure of both entities. Our aim together is to invest in technologies of the future that can revolutionize the care paradigm – with more precise, connected, and compassionate care to patients in India and worldwide.”
The collaboration aligns with the Indian Government's emphasis on fostering local Research and Development (R&D) and Manufacturing in the MedTech sector, necessitating Public-Private Partnership (PPP) models to further drive technology development. Collaborative efforts by both the entities will be deployed for product development and clinical research, improving indigenization of manufacturing and academic activities to strengthen the healthcare ecosystem.
About IISc:
The Indian Institute of Science (IISc) was established in 1909 by a visionary partnership between the industrialist Jamsetji Nusserwanji Tata, the Mysore royal family and the Government of India. Over the last 114 years, IISc has become India’s premier institute for advanced scientific and technological research and education. Its mandate is “to provide for advanced instruction and to conduct original investigations in all branches of knowledge as are likely to promote the material and industrial welfare of India.” In 2018, IISc was selected as an Institution of Eminence (IoE) by the Government of India, and it consistently figures among the top Indian institutions in world university rankings. More information at: https://iisc.ac.in/
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are an $18.3 billion business with 50,000 employees working to create a world where healthcare has no limits. Follow us on Facebook, LinkedIn, X and Insights for the latest news, or visit our website https://www.gehealthcare.in for more information.
For more information, please contact:
- Shipra Singh | +91 9769496988 | shipra.singh@gehealthcare.com
- IISc Office of Communications | news@iisc.ac.in
